126 related articles for article (PubMed ID: 10755070)
1. Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex.
Eastwood SL; Cairns NJ; Harrison PJ
Br J Psychiatry; 2000 Mar; 176():236-42. PubMed ID: 10755070
[TBL] [Abstract][Full Text] [Related]
2. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
[TBL] [Abstract][Full Text] [Related]
3. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia.
Eastwood SL; Burnet PW; Harrison PJ
Neuroscience; 1995 May; 66(2):309-19. PubMed ID: 7477874
[TBL] [Abstract][Full Text] [Related]
4. Synaptophysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study.
Eastwood SL; Burnet PW; McDonald B; Clinton J; Harrison PJ
Neuroscience; 1994 Apr; 59(4):881-92. PubMed ID: 8058126
[TBL] [Abstract][Full Text] [Related]
5. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia.
Glantz LA; Austin MC; Lewis DA
Biol Psychiatry; 2000 Sep; 48(5):389-97. PubMed ID: 10978722
[TBL] [Abstract][Full Text] [Related]
6. Cellular basis of reduced cortical reelin expression in schizophrenia.
Eastwood SL; Harrison PJ
Am J Psychiatry; 2006 Mar; 163(3):540-2. PubMed ID: 16513881
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.
Eastwood SL; Harrison PJ
Schizophr Res; 2005 Mar; 73(2-3):159-72. PubMed ID: 15653259
[TBL] [Abstract][Full Text] [Related]
8. Decreased reelin expression in the left prefrontal cortex (BA9) in chronic schizophrenia patients.
Habl G; Schmitt A; Zink M; von Wilmsdorff M; Yeganeh-Doost P; Jatzko A; Schneider-Axmann T; Bauer M; Falkai P
Neuropsychobiology; 2012; 66(1):57-62. PubMed ID: 22797278
[TBL] [Abstract][Full Text] [Related]
9. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
Glantz LA; Lewis DA
Arch Gen Psychiatry; 1997 Oct; 54(10):943-52. PubMed ID: 9337775
[TBL] [Abstract][Full Text] [Related]
10. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
Glantz LA; Lewis DA
Arch Gen Psychiatry; 1997 Jul; 54(7):660-9. PubMed ID: 9236550
[TBL] [Abstract][Full Text] [Related]
11. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography.
Eastwood SL; Harrison PJ
Neuroscience; 1995 Nov; 69(2):339-43. PubMed ID: 8552231
[TBL] [Abstract][Full Text] [Related]
12. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.
Karson CN; Mrak RE; Schluterman KO; Sturner WQ; Sheng JG; Griffin WS
Mol Psychiatry; 1999 Jan; 4(1):39-45. PubMed ID: 10089007
[TBL] [Abstract][Full Text] [Related]
13. Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections.
Eastwood SL; Harrison PJ
Neuroscience; 1999; 93(1):99-106. PubMed ID: 10430474
[TBL] [Abstract][Full Text] [Related]
14. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders.
Xing G; Zhang L; Russell S; Post R
Schizophr Res; 2006 May; 84(1):36-56. PubMed ID: 16631355
[TBL] [Abstract][Full Text] [Related]
15. Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
Osimo EF; Beck K; Reis Marques T; Howes OD
Mol Psychiatry; 2019 Apr; 24(4):549-561. PubMed ID: 29511299
[TBL] [Abstract][Full Text] [Related]
16. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.
Eastwood SL; Harrison PJ
Brain Res Bull; 2001 Jul; 55(5):569-78. PubMed ID: 11576753
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia.
Eastwood SL; Harrison PJ
Neuroscience; 1998 Sep; 86(2):437-48. PubMed ID: 9881859
[TBL] [Abstract][Full Text] [Related]
18. Gene expression and neuronal activity in schizophrenia: a study of polyadenylated mRNA in the hippocampal formation and cerebral cortex.
Harrison PJ; Burnet PW; Falkai P; Bogerts B; Eastwood SL
Schizophr Res; 1997 Aug; 26(2-3):93-102. PubMed ID: 9323338
[TBL] [Abstract][Full Text] [Related]
19. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia.
Harrison PJ; Eastwood SL
Lancet; 1998 Nov; 352(9141):1669-73. PubMed ID: 9853440
[TBL] [Abstract][Full Text] [Related]
20. Cerebellar synaptic protein expression in schizophrenia.
Eastwood SL; Cotter D; Harrison PJ
Neuroscience; 2001; 105(1):219-29. PubMed ID: 11483314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
